Suppressive effect of inducible nitric oxide synthase (iNOS) expression by the methanol extract of Actinodaphne lancifolia

Phytotherapy Research

Volumn 18, Issue 10, 2004, Pages 853-856

  Kim, Youngleem ^a   Min, Hye Young ^a   Park, Hyen Joo ^a   Lee, Eun Jin ^a   Park, Eun Jung ^a   Hwang, Hye Jin ^a   Jin, Changbae ^b   Lee, Yong Sup ^b   Lee, Sang Kook ^a  

^a Ewha Womans University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

Actinodaphne lancifolia; Inducible nitric oxide synthase (iNOS); Lipopolysaccharide (LPS); Nitric oxide; RAW 264.7 cells

Indexed keywords

ACTINODAPHNE LANCIFOLIA EXTRACT; INDUCIBLE NITRIC OXIDE SYNTHASE; METHANOL DERIVATIVE; NATURAL PRODUCT; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ACTINODAPHNE LANCIFOLIA; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PREVENTION; CARCINOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; IC 50; INFLAMMATION; MACROPHAGE ACTIVATION; MEDICINAL PLANT; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; BLOTTING, WESTERN; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; INHIBITORY CONCENTRATION 50; LAURACEAE; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHYTOTHERAPY; PLANT EXTRACTS; PLANT STEMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ACTINODAPHNE;

EID: 9644304538     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1558     Document Type: Article

References (24)

1. Alley MC, Dominic A, Shoemaker RH. 1988. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48: 589-601.
2. Chan MM, Hunag HI, Fenton MR, Fong D. 1998. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer chemopreventive natural product with anti-inflammatory properties. Biochem Pharmacol 55: 1955-1962.
3. Chartrain NA, Geller DA, Koty PP, et al. 1994. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem 269: 6765-6772.
4. Chiba K, Yamazaki M, Umegaki E, et al. 2002. Neuritogenesis of herbal (+)- and (-)-syringaresinols separated by chiral HPLC in PC12h and Neuro2a cells. Biol Pharm Bull 25: 791-793.
5. Gallo O, Masini E, Morbidelli L, et al. 1998. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 90: 587-596.
6. Geller DA, Kussler AK, DiSilvio M, et al. 1993. Cytokines, endotoxin and glucocorticoids regulate the expression of inducible nitric oxide synthase in hapatocytes. Proc Natl Acad Sci USA 90: 522-426.
7. 15N]nitrate in biological fluids. Anal Biochem 126: 131-138.
8. Hobbs AJ, Higgs A, Moncada S. 1999. Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol 39: 191-220.
9. Kim CM, Shin MK, Lee KS, Ahn DK. 1998. Chinese Medicine Dictionary. Jungdam Co. 6: Seoul, Korea. 3398.
10. Kim M-R, Jung H-J, Min B-S, et al. 2002. Constituents from the stems of Actinodaphne lancifolia. Phytochemistry 59: 861-865.
11. Kim NY, Ryu J-H. 2003. Butanolides from Machilus thunbergii and their inhibitory activity on nitric oxide synthase in activated macrophages. Phytother Res 17: 372-375.
12. Kröncke KD, Fehsel K, Kolb-Bachofen V. 1998. Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 113: 147-156.
13. Kuo C-C, Chiang WC, Liu G-P, et al. 2002. 2,2′-Diphenyl-1- picrylhydrazyl radical-scavenging active components from Adlay (Coix lachryma-jobi L. var. ma-yuen Stapf) Hulls. J Agri Food Chem 50: 5850-5855.
14. Lyons CR, Orloff GJ, Cunningham JM. 1992. Molecular cloning and functional expression of an inducible nitric oxide synthase in RAW 264.7 macrophages. Mol Pharmacol 41: 615-624.
15. Mordan LJ, Burnett TS, Zhang LX, et al. 1993. Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H10T1/2 fibroblasts. Carcinogenesis 14: 1555-1559.
16. Nathan C, Xie Q-W. 1994. Regulation of biosynthesis of nitric oxide. J Biol Chem 269: 13725-13728.
17. Ohshima H, Bartsch H. 1994. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 305: 253-264.
18. Rao CV, Indranie C, Simi B, et al. 2002. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res 62: 165-170.
19. Rosbe KW, Prazma J, Petrusz P, et al. 1995. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 113: 541-549.
20. Schmidt HH, Warner TD, Nakane M, et al. 1992. Regulation and sucellular location of nitrogen oxide synthase in RAW 264.7 macrophages. Mol Pharmacol 41: 615-624.
21. Tanaka H, Nakamura T, Ichino K, Ito K. 1989. Two lactonic compounds, lancifolide and isolancifolide, from Actinodaphne lancifolia. Phytochemistry 28: 626-628.
22. Thomsen LL, Miles DW, Happerfield L, et al. 1995. Nitric oxide synthase activity in human breast cancer. Br J Cancer 72: 41-45.
23. Toshihiko K, Ronald L, Vernon ES, et al. 1999. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression atage of colon cancer. Cancer Res 59: 597-601.
24. Wiseman H, Halliwell B. 1996. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory diesase and progression to cancer. Biochem J 313: 17-29.